Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]

Intan Sofia Omar; Noor Azmi Mat Adenan; Alejandro Godoy; Ik Hui Teo; Yogeeta Gunasagran; Ivy Chung

doi:10.1016/j.bbrc.2022.12.065

Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]

Intan Sofia Omar, Noor Azmi Mat Adenan, Alejandro Godoy, Ik Hui Teo, Yogeeta Gunasagran, Ivy Chung^*

^*Autor correspondiente de este trabajo

Producción científica: Contribución a una revista › Comentario/Debate

Resumen

The authors would like to add details of the grant in the Acknowledgements as below: Acknowledgements This research was supported by Malaysian Ministry of Higher Education through Fundamental Research Grant Scheme (FRGS, FP029-2014B; grant code: FRGS/2/2014/SKK01/UM/02/1). This work was also supported by Universiti Malaya High Impact Research Grant (UM.C/625/HIR/MED/12) with no direct involvement in the conduct and writing of this study. The authors thank Universiti Malaya Tissue Biobank Unit and Translational Core Laboratory for supporting research activities. The authors would like to apologize for any inconvenience caused.

Idioma original	Inglés
Páginas (desde-hasta)	202
Número de páginas	1
Publicación	Biochemical and Biophysical Research Communications
Volumen	640
DOI	https://doi.org/10.1016/j.bbrc.2022.12.065
Estado	Publicada - 2023

Nota bibliográfica

Publisher Copyright:
© 2022 Elsevier Inc.

Áreas temáticas de ASJC Scopus

Biofísica
Bioquímica
Biología molecular
Biología celular

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/j.bbrc.2022.12.065

Otros archivos y enlaces

Enlace a la publicación en Scopus

Huella

Profundice en los temas de investigación de 'Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]'. En conjunto forman una huella única.

Citar esto

Omar, I. S., Mat Adenan, N. A., Godoy, A., Teo, I. H., Gunasagran, Y., & Chung, I. (2023). Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]. Biochemical and Biophysical Research Communications, 640, 202. https://doi.org/10.1016/j.bbrc.2022.12.065

Omar, Intan Sofia ; Mat Adenan, Noor Azmi ; Godoy, Alejandro et al. / Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]. En: Biochemical and Biophysical Research Communications. 2023 ; Vol. 640. pp. 202.

@article{2864f204e38d480db8dfda62e98dba8f,

title = "Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]",

abstract = "The authors would like to add details of the grant in the Acknowledgements as below: Acknowledgements This research was supported by Malaysian Ministry of Higher Education through Fundamental Research Grant Scheme (FRGS, FP029-2014B; grant code: FRGS/2/2014/SKK01/UM/02/1). This work was also supported by Universiti Malaya High Impact Research Grant (UM.C/625/HIR/MED/12) with no direct involvement in the conduct and writing of this study. The authors thank Universiti Malaya Tissue Biobank Unit and Translational Core Laboratory for supporting research activities. The authors would like to apologize for any inconvenience caused.",

author = "Omar, {Intan Sofia} and {Mat Adenan}, {Noor Azmi} and Alejandro Godoy and Teo, {Ik Hui} and Yogeeta Gunasagran and Ivy Chung",

note = "Funding Information: This research was supported by Malaysian Ministry of Higher Education through Fundamental Research Grant Scheme (FRGS, FP029-2014B; grant code: FRGS/2/2014/SKK01/UM/02/1). This work was also supported by Universiti Malaya High Impact Research Grant (UM.C/625/HIR/MED/12) with no direct involvement in the conduct and writing of this study. The authors thank Universiti Malaya Tissue Biobank Unit and Translational Core Laboratory for supporting research activities. Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2023",

month = jan,

day = "15",

doi = "10.1016/j.bbrc.2022.12.065",

language = "English",

volume = "640",

pages = "202",

journal = "Biochemical and Biophysical Research Communications",

issn = "0006-291X",

publisher = "Elsevier B.V.",

}

Omar, IS, Mat Adenan, NA, Godoy, A, Teo, IH, Gunasagran, Y & Chung, I 2023, 'Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]', Biochemical and Biophysical Research Communications, vol. 640, pp. 202. https://doi.org/10.1016/j.bbrc.2022.12.065

Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]. / Omar, Intan Sofia; Mat Adenan, Noor Azmi; Godoy, Alejandro et al.
En: Biochemical and Biophysical Research Communications, Vol. 640, 15.01.2023, p. 202.

Producción científica: Contribución a una revista › Comentario/Debate

TY - JOUR

T1 - Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]

AU - Omar, Intan Sofia

AU - Mat Adenan, Noor Azmi

AU - Godoy, Alejandro

AU - Teo, Ik Hui

AU - Gunasagran, Yogeeta

AU - Chung, Ivy

N1 - Funding Information: This research was supported by Malaysian Ministry of Higher Education through Fundamental Research Grant Scheme (FRGS, FP029-2014B; grant code: FRGS/2/2014/SKK01/UM/02/1). This work was also supported by Universiti Malaya High Impact Research Grant (UM.C/625/HIR/MED/12) with no direct involvement in the conduct and writing of this study. The authors thank Universiti Malaya Tissue Biobank Unit and Translational Core Laboratory for supporting research activities. Publisher Copyright: © 2022 Elsevier Inc.

PY - 2023/1/15

Y1 - 2023/1/15

N2 - The authors would like to add details of the grant in the Acknowledgements as below: Acknowledgements This research was supported by Malaysian Ministry of Higher Education through Fundamental Research Grant Scheme (FRGS, FP029-2014B; grant code: FRGS/2/2014/SKK01/UM/02/1). This work was also supported by Universiti Malaya High Impact Research Grant (UM.C/625/HIR/MED/12) with no direct involvement in the conduct and writing of this study. The authors thank Universiti Malaya Tissue Biobank Unit and Translational Core Laboratory for supporting research activities. The authors would like to apologize for any inconvenience caused.

AB - The authors would like to add details of the grant in the Acknowledgements as below: Acknowledgements This research was supported by Malaysian Ministry of Higher Education through Fundamental Research Grant Scheme (FRGS, FP029-2014B; grant code: FRGS/2/2014/SKK01/UM/02/1). This work was also supported by Universiti Malaya High Impact Research Grant (UM.C/625/HIR/MED/12) with no direct involvement in the conduct and writing of this study. The authors thank Universiti Malaya Tissue Biobank Unit and Translational Core Laboratory for supporting research activities. The authors would like to apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85145954713&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2022.12.065

DO - 10.1016/j.bbrc.2022.12.065

M3 - Comment/debate

C2 - 36593136

AN - SCOPUS:85145954713

SN - 0006-291X

VL - 640

SP - 202

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

ER -

Omar IS, Mat Adenan NA, Godoy A, Teo IH, Gunasagran Y, Chung I. Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]. Biochemical and Biophysical Research Communications. 2023 ene. 15;640:202. doi: 10.1016/j.bbrc.2022.12.065